Search

Your search keyword '"Origuchi, Tomoki"' showing total 898 results

Search Constraints

Start Over You searched for: Author "Origuchi, Tomoki" Remove constraint Author: "Origuchi, Tomoki"
898 results on '"Origuchi, Tomoki"'

Search Results

201. A case of compressive optic neuropathy putatively caused by IgG4-related idiopathic orbital inflammation

202. Japan College of Rheumatology

204. Effects of continuous passive motion on the expression of membrane type 1-matrix metalloproteinase in rat immobilized muscles

205. Japan College of Rheumatology

206. 日本内科学会

207. Japan College of Rheumatology

208. M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis

209. Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules

210. MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway

211. Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled

212. Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis

213. Giant cell arteritis complicated with microscopic polyangiitis: two cases

214. P2_93 Renal Involvements in ANCA Associated Vasculitis

216. Deep vein thrombosis and pulmonary thromboembolism in a patient with eosinophilia and obesity

217. The Japanese Society of Internal Medicine

218. The Japanese Society of Internal Medicine

219. The Japanese Society of Internal Medicine

220. Antineutrophilic cytoplasmic antibody‐associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not.

221. Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled

222. Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis

223. Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan

224. Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years

225. A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

226. Synovitis of sternoclavicular and peripheral joints can be detected by ultrasound in patients with SAPHO syndrome

227. Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years

228. Assessment of both articular synovitis and tenosynovitis by ultrasound is useful for evaluations of hand dysfunction in early rheumatoid arthritis patients

229. Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs

230. Clinical outcomes in the first year of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome

231. Magnetic Resonance Imaging Bone Edema at Enrollment Predicts Rapid Radiographic Progression in Patients with Early RA: Results from the Nagasaki University Early Arthritis Cohort

232. Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice

233. Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever

234. Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis

235. The Japanese Society of Internal Medicine

236. Effect of a gonadotropin‐releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.

237. Giant Cell Arteritis which Developed after the Administration of Granulocyte-colony Stimulating Factor for Cyclic Neutropenia

238. The Severity of Takayasu Arteritis Is Associated with the HLA-B52 Allele in Japanese Patients

239. Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy

241. Hypocholesterolemia predicts relapses in patients with Takayasu arteritis

244. Automated Breast Volume Scanner, a new automated ultrasonic device, is useful to examine joint injuries in patients with rheumatoid arthritis

245. Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease

246. Upregulation of Thrombospondin 1 Expression in Synovial Tissues and Plasma of Rheumatoid Arthritis: Role of Transforming Growth Factor-β1 toward Fibroblast-like Synovial Cells

247. Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co‐Occurrence and Genetic Overlap

248. Effects of joint immobilization on changes in myofibroblasts and collagen in the rat knee contracture model.

249. Risk factors of adverse events during treatment in elderly patients with rheumatoid arthritis: an observational study.

250. Diffuse Alveolar Hemorrhage Emerging One Week after Starting High-dose Corticosteroid Therapy for Granulomatosis with Polyangiitis (GPA) with Systemic Lupus Erythematosus (SLE)

Catalog

Books, media, physical & digital resources